Document:

Seventh Amendment to Loan and Security Agreement

 Exhibit 10.3 
 SEVENTH AMENDMENT TO LOAN AND SECURITY AGREEMENT 
 THIS SEVENTH AMENDMENT TO LOAN AND SECURITY
AGREEMENT (this “Amendment”), dated as of July 31, 2009, is entered into by and among the financial institutions signatory hereto (each a “Lender” and collectively the “Lenders”), BANK
OF AMERICA, N.A., as administrative agent for the Lenders (in such capacity, “Agent”), NAUTILUS, INC., a Washington corporation (“US Borrower”), and NAUTILUS INTERNATIONAL S.A., a
Swiss private share company (“Swiss Borrower”, and together with US Borrower, collectively, “Borrowers”). 
 RECITALS 
 A. Borrowers, Agent and the Lenders have previously entered into that certain Loan and Security Agreement dated
as of January 16, 2008 (as amended, supplemented, restated and modified from time to time, the “Loan Agreement”), pursuant to which the Lenders have made certain loans and financial accommodations available to Borrowers. Terms
used herein without definition shall have the meanings ascribed to them in the Loan Agreement. 
 B. Borrowers, Agent and the Lenders now
wish to amend the Loan Agreement on the terms and conditions set forth herein. 
 AGREEMENT 
 NOW, THEREFORE, in consideration of the foregoing and the mutual covenants herein contained, and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereby agree as follows: 
 1. Amendments to Loan Agreement. 

(a) The definition of “EBITDA” in Section 1.1 of the Loan Agreement is hereby amended and restated in its entirety to read as follows:

 “EBITDA: determined on a consolidated basis for Borrowers and Subsidiaries, net income, calculated before (in each case, to the
extent included in determining net income and to the extent incurred or attributable during the applicable measurement period) (i) interest expense, (ii) provision for income taxes, (iii) depreciation and amortization expense,
(iv) gains or losses arising from the sale of capital assets, (v) gains arising from the write-up of assets, (vi) any extraordinary gains, (vii) non-recurring charges during the month of December 2008 as listed on Schedule
E hereto, (viii) up to $8,000,000 in non-cash expenses incurred during the first and second Fiscal Quarters of 2009 in connection with the write-down of leasehold improvements for Borrowers’ headquarters in Vancouver, Washington, and
(ix) up to $4,500,000 of expenses incurred during the first and second Fiscal Quarters of 2009 in connection with severance costs and/or other expenses incurred in connection with the termination of the leases covering Borrowers’ Tulsa,
Oklahoma location and Vancouver, Washington headquarters.” 
 2. Effectiveness of this Amendment. The following shall have
occurred before this Amendment is effective: 
 (a) Amendment. Agent shall have received this Amendment fully executed in a sufficient
number of counterparts for distribution to all parties. 

 (b) Representations and Warranties. The representations and warranties set forth herein must be
true and correct. 
 (c) No Default. No event has occurred and is continuing that constitutes an Event of Default. 
 (d) Other Required Documentation. All other documents and legal matters in connection with the transactions contemplated by this Amendment shall
have been delivered or executed or recorded and shall be in form and substance satisfactory to Agent. 
 3. Representations and
Warranties. Each Borrower represents and warrants as follows: 
 (a) Authority. Such Borrower has the requisite corporate power
and authority to execute and deliver this Amendment, and to perform its obligations hereunder and under the Loan Documents (as amended or modified hereby) to which it is a party. The execution, delivery and performance by such Borrower of this
Amendment have been duly approved by all necessary corporate action and no other corporate proceedings are necessary to consummate such transactions. 
 (b) Enforceability. This Amendment has been duly executed and delivered by such Borrower. This Amendment and each Loan Document to which such Borrower is a party (as amended or modified hereby) is the legal,
valid and binding obligation of such Borrower, enforceable against such Borrower in accordance with its terms, and is in full force and effect. 
 (c) Representations and Warranties. The representations and warranties contained in each Loan Document to which such Borrower is a party (other than any such representations or warranties that, by their terms, are specifically made
as of a date other than the date hereof) are correct on and as of the date hereof as though made on and as of the date hereof. 
 (d) Due
Execution. The execution, delivery and performance of this Amendment are within the power of such Borrower, have been duly authorized by all necessary corporate action, have received all necessary governmental approval, if any, and do not
contravene any law or any contractual restrictions binding on such Borrower. 
 (e) No Default. No event has occurred and is
continuing that constitutes an Event of Default. 
 4. Choice of Law. The validity of this Amendment, its construction, interpretation
and enforcement, the rights of the parties hereunder, shall be determined under, governed by, and construed in accordance with the internal laws of the State of California, without giving effect to any conflict of law principles (but giving effect
to Federal laws relating to national banks). The consent to forum and arbitration provisions set forth in Section 14.14 of the Loan Agreement are hereby incorporated in this Amendment by reference. 
 5. Counterparts. This Amendment may be executed in any number of counterparts and by different parties and separate counterparts, each of which
when so executed and delivered, shall be deemed an original, and all of which, when taken together, shall constitute one and the same instrument. Delivery of an executed counterpart of a signature page to this Amendment by telefacsimile or a
substantially similar electronic transmission shall have the same force and effect as the delivery of an 

  

 2 

 
original executed counterpart of this Amendment. Any party delivering an executed counterpart of this Amendment by telefacsimile or a substantially similar
electronic transmission shall also deliver an original executed counterpart, but the failure to do so shall not affect the validity, enforceability or binding effect of such agreement. 
 6. Reference to and Effect on the Loan Documents. 
 (a) Upon and after the effectiveness of this Amendment, each reference in the Loan Agreement to “this Agreement”, “hereunder”, “hereof” or words of like import referring to the Loan
Agreement, and each reference in the other Loan Documents to “the Loan Agreement”, “thereof” or words of like import referring to the Loan Agreement, shall mean and be a reference to the Loan Agreement as modified and amended
hereby. 
 (b) Except as specifically amended above, the Loan Agreement and all other Loan Documents, are and shall continue to be in full
force and effect and are hereby in all respects ratified and confirmed and shall constitute the legal, valid, binding and enforceable obligations of Borrowers to Agent and the Lenders. 
 (c) The execution, delivery and effectiveness of this Amendment shall not, except as expressly provided herein, operate as a waiver of any right, power
or remedy of Agent or any Lender under any of the Loan Documents, nor constitute a waiver of any provision of any of the Loan Documents. 
 (d) To the extent that any terms and conditions in any of the Loan Documents shall contradict or be in conflict with any terms or conditions of the Loan Agreement, after giving effect to this Amendment, such terms and conditions are hereby
deemed modified or amended accordingly to reflect the terms and conditions of the Loan Agreement as modified or amended hereby. 
 7.
Ratification. Each Borrower hereby restates, ratifies and reaffirms each and every term and condition set forth in the Loan Agreement, as amended hereby, and the Loan Documents effective as of the date hereof. 
 8. Estoppel. To induce Lenders to enter into this Amendment and to continue to make advances to Borrowers under the Loan Agreement, each Borrower
hereby acknowledges and agrees that, as of the date hereof, there exists no right of offset, defense, counterclaim or objection in favor of such Borrower as against Agent or any Lender with respect to the Obligations. 
 9. Integration. This Amendment, together with the other Loan Documents, incorporates all negotiations of the parties hereto with respect to the
subject matter hereof and is the final expression and agreement of the parties hereto with respect to the subject matter hereof. 
 10.
Severability. In case any provision in this Amendment shall be invalid, illegal or unenforceable, such provision shall be severable from the remainder of this Amendment and the validity, legality and enforceability of the remaining provisions
shall not in any way be affected or impaired thereby. 
 [Remainder of Page Left Intentionally Blank] 
  

 3 

 IN WITNESS WHEREOF, the parties have entered into this Amendment as of the date first above written.

  

			
	 BORROWERS
  
 NAUTILUS, INC., a Washington corporation

		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	NAUTILUS INTERNATIONAL S.A., a Swiss private share company
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  

 4 

			
	 AGENT AND LENDERS
  
 BANK OF AMERICA, N.A.,
 as Agent and as sole
Lender

		
	By:	 	  

	Name:	 	  

	Title:	 	  

  

 5Directors Plan Amendment

 Exhibit 10.1 
 Directors Plan Amendment 
 UNIGENE LABORATORIES, INC. 
 AMENDMENT TO DIRECTORS STOCK OPTION PLAN 
 Pursuant to Section 10 of the Unigene Laboratories, Inc. Directors Stock Option Plan (the “Plan”), the Board of Directors of Unigene Laboratories, Inc. (the “Company”) hereby amends the Plan as set forth herein,
effective as of June 25, 2009. 
 1. Section 6(d) of the Plan is amended and restated in its entirety as follows: 
 “Except as otherwise determined by the Board in its discretion at any time, any Option that has not theretofore expired shall terminate 90 days
following the termination of the Participant’s service as a director of the Company for any reason, and no shares of Common Stock may thereafter be purchased pursuant to such Option, except that: 
 (i) Upon the resignation of a Participant as a director due to disability, the Participant may, within a 180-day period after the date of such
termination, purchase all or any part of the shares of Common Stock that such Participant was entitled to purchase under such Option on the date of such termination. 
 (ii) Upon the death of a Participant while serving as a director or within the 90-day period referred to above, the Participant’s estate or the person to whom such Participant’s rights under the Option are
transferred by will or the laws of descent and distribution may, within a 180-day period after the date of such Participant’s death, purchase all or any part of the shares of Common Stock that such Participant was entitled to purchase under
such Option on the date of death.” 
 2. Except as specifically set forth and changed herein, the Plan is reaffirmed and remains
unchanged. 
 [The remainder of this page is intentionally blank.] 

 IN WITNESS WHEREOF, the Company has caused this Amendment to the Plan to be executed and its seal to be
affixed hereto by its officers hereunto duly authorized, as of the date first above written. 
  

			
	 UNIGENE LABORATORIES, INC.

		
	 By:
	 	  

  

	
	ATTEST:
	
	  

	Secretary

 [SEAL]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}]]